Assessment of the Efficacy of the Dynamic Decongestive System in the Maintenance Phase of Lower Limb Lymphedema

Brief Summary

The trial aims to compare the dynamic compression device in combination with elastic compression garments is non-inferior to all currently available compression devices (CACD) during the maintenance phase of lower limb lymphoedema treatment. The trial involves 2 parallel groups. Both groups will include patients who are being discharged from the inpatient intensive treatment phase for lower limb lymphoedema. Eligible participants will be enrolled in the study on the afternoon of their last inpatient treatment day, prior to discharge. DDS group: elastic compression garment at least during the day and as often as possible during the night (depending on personal preferences and expert advice) + DDS for a minimum of 2h at the end of the day (alone without an elastic garment). Control group: elastic compression garment at least during the day and as often as possible during the night (depending on personal preferences and expert advice) + all currently available compression devices (CACD), including multicomponent bandages, pneumatic compression devices, and compression wraps, depending on patient preference and the center's recommendations. Manual lymphatic drainage will be acceptable for both groups. Patients will be assessed during three measurement sessions: Visit 1 / baseline-inclusion (V1) - on the afternoon of their last inpatient treatment day, prior to discharge from intensive treatment, Visit 2 (V2) - at the end of week 6 (± 7 days) Visit 3 (V3) - at the end of week 12 (± 7 days)